Director/PDMR Shareholding

Primary Health Properties PLC
08 March 2024
 

 Primary Health Properties PLC

Director's & PDMR dealings

On 5 March 2024, the remuneration committee of Primary Health Properties PLC (the "Company" or "PHP") made the following awards of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to a Director and Persons Discharging Managerial Responsibilities ("PDMR's").

Director

Number of shares under option

Richard Howell

539,779

PDMR


David Bateman

348,137

Toby Newman

115,488

David Austin

131,109

 

The number of nil-cost options were calculated by reference to a price of £0.8962, being the average of the closing middle market quotations for the Company's ordinary shares on 28 February 2024, 29 February 2024 and 1 March 2024. 

The nil-cost options will normally vest on the third anniversary of grant, subject to the attainment of performance conditions.  The remuneration committee has the discretion to adjust the awards downwards at vesting for malus reasons.  Details of the operation of the LTIP are set out in the Company's 2022 Report and Accounts.

Details of the transactions referenced above are included below in accordance with the under Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Richard Howell

 

2

Reason for notification

(a)

Position/Status

Chief Financial Officer

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

 

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

539,779

 

(d)

Aggregated Information

Single transaction: N/A

 

(e)

Date of transaction

7 March 2024

 

(f)

Place of transaction

N/A

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

David Bateman

 

2

Reason for notification

(a)

Position/Status

PDMR

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

 

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

348,137

 

(d)

Aggregated Information

Single transaction: N/A

 

(e)

Date of transaction

7 March 2024

 

(f)

Place of transaction

N/A

 

 

1

Details of the person discharging managerial responsibility/person closely associated

(a)

Name

Toby Newman

 

2

Reason for notification

(a)

Position/Status

Company Secretary & Chief Legal Officer

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

 

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

115,488

 

(d)

Aggregated Information

Single transaction: N/A

 

(e)

Date of transaction

7 March 2024

 

(f)

Place of transaction

N/A

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

David Austin

 

2

Reason for notification

(a)

Position/Status

PDMR

(b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

(a)

Name

 

Primary Health Properties PLC

(b)

LEI

213800Y5CJHXOATK7X11

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14

(b)

Nature of transaction

Award of nil-cost options over the Company's ordinary shares

 

(c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

131,109

 

(d)

Aggregated Information

Single transaction: N/A

 

(e)

Date of transaction

7 March 2024

 

(f)

Place of transaction

N/A

 

 

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk 

 

Further details:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 7973 344768

Steven Owen

Chairman

Tel: +44 (0) 203 8241 841

Richard Howell

Chief Financial Officer

Tel: +44 (0) 7766 072272


David Rydell / Stephanie Whitmore (Buchanan Communications)

Tel: +44 (0) 20 7466 5066


 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings